• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿 CXCL10 作为预测 Hunner 型间质性膀胱炎的生物标志物的诊断价值。

Diagnostic value of urinary CXCL10 as a biomarker for predicting Hunner type interstitial cystitis.

机构信息

Department of Urology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.

Department of Continence Medicine, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.

出版信息

Neurourol Urodyn. 2018 Mar;37(3):1113-1119. doi: 10.1002/nau.23431. Epub 2017 Oct 19.

DOI:10.1002/nau.23431
PMID:29048741
Abstract

AIM

To investigate the feasibility of chemokines and cytokines potentially elevated in the bladder tissue of Hunner type interstitial cystitis (HIC) as urinary markers for distinguishing HIC from non-Hunner type interstitial cystitis (NHIC) METHODS: Urine specimens were collected from 41 HIC patients, 25 NHIC patients, and 31 healthy volunteers (control). The supernatants of urine specimens were subjected to ELISA kits for measurements of 10 cytokines and chemokines, whose gene expression was known to be elevated in HIC bladder tissue. Urinary levels normalized by urinary creatinine (Cr) concentration were compared among three groups. Efficiency in differentiating IC and IC subtypes was explored by ROC analysis. The correlation of marker levels with symptom severity, assessed by O'Leary-Sant's symptom index (OSSI) and problem index (OSPI), was examined.

RESULTS

The urinary levels of CXCL10 and NGF were significantly higher in HIC than NHIC. CXCL10 and NGF differentiated HIC against NHIC with AUC of 0.78 and 0.68, respectively. Combination of CXCL10 and NGF levels yielded an AUS of 0.81. The CXCL10 cut-off of 53.2 pg/mg Cr had sensitivity of 46.1%, specificity of 93.7%, positive predictive value of 97.7%, and negative predictive value of 60.0%. The urinary level of other cytokines showed no significant difference between HIC and NHIC. Significant correlation with symptoms was detected for CXCL10 alone.

CONCLUSION

The results suggested that increased urinary level of CXCL10 combined with or without high NGF level could be a promising supplementary biomarker for differentiating HIC from NHIC with modest sensitivity and high specificity.

摘要

目的

探讨在 Hunner 型间质性膀胱炎(HIC)膀胱组织中潜在升高的趋化因子和细胞因子是否可作为尿标志物,用于区分 HIC 与非 Hunner 型间质性膀胱炎(NHIC)。

方法

收集 41 例 HIC 患者、25 例 NHIC 患者和 31 例健康志愿者(对照组)的尿标本。采用 ELISA 试剂盒检测尿液标本上清液中已知在 HIC 膀胱组织中表达升高的 10 种细胞因子和趋化因子。通过尿肌酐(Cr)浓度对尿液水平进行归一化,并比较三组之间的差异。通过 ROC 分析探讨标志物水平在区分 IC 和 IC 亚型中的效率。检查标志物水平与 O'Leary-Sant 症状指数(OSSI)和问题指数(OSPI)评估的症状严重程度之间的相关性。

结果

与 NHIC 相比,HIC 患者的尿 CXCL10 和 NGF 水平显著升高。CXCL10 和 NGF 分别以 AUC 为 0.78 和 0.68 区分 HIC 与 NHIC。联合检测 CXCL10 和 NGF 水平的 AUC 为 0.81。CXCL10 的截断值为 53.2pg/mg Cr,其敏感性为 46.1%,特异性为 93.7%,阳性预测值为 97.7%,阴性预测值为 60.0%。HIC 与 NHIC 之间其他细胞因子的尿液水平无显著差异。仅 CXCL10 与症状显著相关。

结论

结果表明,CXCL10 尿水平升高结合或不结合高 NGF 水平可能是一种有前途的辅助生物标志物,用于区分 HIC 与 NHIC,其敏感性适中,特异性较高。

相似文献

1
Diagnostic value of urinary CXCL10 as a biomarker for predicting Hunner type interstitial cystitis.尿 CXCL10 作为预测 Hunner 型间质性膀胱炎的生物标志物的诊断价值。
Neurourol Urodyn. 2018 Mar;37(3):1113-1119. doi: 10.1002/nau.23431. Epub 2017 Oct 19.
2
Hunner-Type (Classic) Interstitial Cystitis: A Distinct Inflammatory Disorder Characterized by Pancystitis, with Frequent Expansion of Clonal B-Cells and Epithelial Denudation.亨纳型(经典型)间质性膀胱炎:一种以全膀胱炎为特征的独特炎症性疾病,常伴有克隆性B细胞扩增和上皮剥脱。
PLoS One. 2015 Nov 20;10(11):e0143316. doi: 10.1371/journal.pone.0143316. eCollection 2015.
3
Downregulation of WNT11 is associated with bladder tissue fibrosis in patients with interstitial cystitis/bladder pain syndrome without Hunner lesion.WNT11 的下调与 Hunner 病变阴性的间质性膀胱炎/膀胱疼痛综合征患者的膀胱组织纤维化有关。
Sci Rep. 2018 Jun 28;8(1):9782. doi: 10.1038/s41598-018-28093-7.
4
Comparison of inflammatory urine markers in patients with interstitial cystitis and overactive bladder.间质性膀胱炎和膀胱过度活动症患者尿液炎症标志物的比较。
Int Urogynecol J. 2018 Jul;29(7):961-966. doi: 10.1007/s00192-017-3547-5. Epub 2018 Jan 25.
5
Neutrophil-to-lymphocyte ratio as a promising non-invasive biomarker for symptom assessment and diagnosis of interstitial cystitis/bladder pain syndrome.中性粒细胞与淋巴细胞比值作为一种有前途的非侵入性生物标志物,可用于评估症状和诊断间质性膀胱炎/膀胱疼痛综合征。
BMC Urol. 2023 Nov 8;23(1):180. doi: 10.1186/s12894-023-01353-z.
6
Angiogenesis in bladder tissues is strongly correlated with urinary frequency and bladder pain in patients with interstitial cystitis/bladder pain syndrome.在间质性膀胱炎/膀胱疼痛综合征患者中,膀胱组织中的血管生成与尿频和膀胱疼痛强烈相关。
Int J Urol. 2019 Jun;26 Suppl 1:35-40. doi: 10.1111/iju.13972.
7
Extent of Hunner lesions: The relationships with symptom severity and clinical parameters in Hunner type interstitial cystitis patients.Hunner 病变范围:与 Hunner 型间质性膀胱炎患者症状严重程度和临床参数的关系。
Neurourol Urodyn. 2018 Apr;37(4):1441-1447. doi: 10.1002/nau.23467. Epub 2018 Jan 9.
8
Usefulness of Urinary Biomarkers for Assessing Bladder Condition and Histopathology in Patients with Interstitial Cystitis/Bladder Pain Syndrome.尿生物标志物在评估间质性膀胱炎/膀胱疼痛综合征患者膀胱状况和组织病理学中的作用。
Int J Mol Sci. 2022 Oct 10;23(19):12044. doi: 10.3390/ijms231912044.
9
Cystectomy for patients with Hunner-type interstitial cystitis at a tertiary referral center in Japan.日本一家三级转诊中心对 Hunner 型间质性膀胱炎患者进行的膀胱切除术。
Low Urin Tract Symptoms. 2022 Mar;14(2):102-108. doi: 10.1111/luts.12416. Epub 2021 Oct 26.
10
Comparative analysis of surgical prognostic between HIC and NHIC patients after cystoscopy with hydrodistention.膀胱镜下注水扩张术后 HIC 与 NHIC 患者手术预后的比较分析。
Medicine (Baltimore). 2024 Sep 20;103(38):e39640. doi: 10.1097/MD.0000000000039640.

引用本文的文献

1
Characteristic genes and immune landscape of interstitial cystitis.间质性膀胱炎的特征基因与免疫格局
PLoS One. 2025 May 28;20(5):e0320249. doi: 10.1371/journal.pone.0320249. eCollection 2025.
2
Integrating biomarker clustering for improved diagnosis of interstitial cystitis/bladder pain syndrome: a review.整合生物标志物聚类以改善间质性膀胱炎/膀胱疼痛综合征的诊断:综述
Int Urol Nephrol. 2025 Mar 15. doi: 10.1007/s11255-025-04452-y.
3
Focal or diffuse bladder wall thickness on bladder computed tomography indicates more severe bladder wall inflammation in patients with interstitial cystitis.
膀胱计算机断层扫描显示的局灶性或弥漫性膀胱壁增厚表明间质性膀胱炎患者的膀胱壁炎症更严重。
World J Urol. 2025 Feb 4;43(1):100. doi: 10.1007/s00345-025-05451-5.
4
Cytokines in Bladder Pain Syndrome: A Review of the Literature.膀胱疼痛综合征中的细胞因子:文献综述。
Int Urogynecol J. 2024 Jun;35(6):1119-1129. doi: 10.1007/s00192-024-05778-4. Epub 2024 May 21.
5
Lower Urinary Tract Inflammation and Infection: Key Microbiological and Immunological Aspects.下尿路炎症与感染:关键的微生物学和免疫学方面
J Clin Med. 2024 Jan 5;13(2):315. doi: 10.3390/jcm13020315.
6
Th1/17 polarization and potential treatment by an anti-interferon-γ DNA aptamer in Hunner-type interstitial cystitis.1型辅助性T细胞/17型辅助性T细胞极化及抗干扰素-γ DNA适配体对间质性膀胱炎的潜在治疗作用
iScience. 2023 Oct 21;26(11):108262. doi: 10.1016/j.isci.2023.108262. eCollection 2023 Nov 17.
7
Usefulness of Urinary Biomarkers for Assessing Bladder Condition and Histopathology in Patients with Interstitial Cystitis/Bladder Pain Syndrome.尿生物标志物在评估间质性膀胱炎/膀胱疼痛综合征患者膀胱状况和组织病理学中的作用。
Int J Mol Sci. 2022 Oct 10;23(19):12044. doi: 10.3390/ijms231912044.
8
Can We Use Urinary Cytokine/Chemokine Analysis in Discriminating Ulcer-Type Interstitial Cystitis/Bladder Pain Syndrome?我们能否使用尿细胞因子/趋化因子分析来鉴别溃疡型间质性膀胱炎/膀胱疼痛综合征?
Diagnostics (Basel). 2022 Apr 27;12(5):1093. doi: 10.3390/diagnostics12051093.
9
Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome with and without Hunner Lesion: A Review and Future Perspectives.伴有和不伴有Hunner病变的间质性膀胱炎/膀胱疼痛综合征中的生物标志物:综述与未来展望
Diagnostics (Basel). 2021 Nov 30;11(12):2238. doi: 10.3390/diagnostics11122238.
10
Comparison of deep phenotyping features of UCPPS with and without Hunner lesion: A MAPP-II Research Network Study.UCPPS 伴有和不伴有 Hunner 病变的深度表型特征比较:MAPP-II 研究网络研究。
Neurourol Urodyn. 2021 Mar;40(3):810-818. doi: 10.1002/nau.24623. Epub 2021 Feb 19.